Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole 40 mg and GERD symptom endpoint evaluation
2006-004882-32Phase 4Completed
- Sponsor
- Altana Pharma
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pantoprazole in gastroesophageal reflux disease (GERD), sponsored by Altana Pharma. Primary endpoint: Misclassification rate between physician-assessed heartburn and patient-reported GERD-related symptoms. Started Oct 2006; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2006-004882-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004882-32.